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The anticancer drug cisplatin, cis-[Pt(NH 3 ) 2 Cl 2 ] (1, Scheme 1) is effective against many different types of cancer (Boulikas and Vougiouka, 2004; Rosenberg, 1971; Eastman, 1999; Wang and Lippard, 2005) . The clinical formulation of cisplatin, in 154 mM aqueous NaCl, contains a mixture of species, being mainly 1 with some of the monoaquated species, cis-[Pt(NH 3 ) 2 Cl(H 2 O)] + , 2 (Miller and House, 1990) . Introduction of the drug into blood, which has a lower chloride concentration (~105 mM), leads to formation of additional 2. Since the pK a for deprotonation of 2 is 6.53 (Miller and House, 1990; Berners-Price and Appleton, 2000) , 2 exists mainly in the deprotonated hydroxo form, cis-[Pt(NH 3 ) 2 Cl(OH)], 3, at physiological pH.
Earlier (Centerwall et al., 2005) we used 15 N-labeled 1 and 1 H-15 N heteronuclear single quantum coherence (HSQC) NMR to show that 3 rapidly reacts with carbonate in culture medium, most likely with dissolved CO 2 (Palmer and van Eldik, 1983; Acharya, et al., 2004) to form the carbonato complex, cis-[Pt(NH 3 ) 2 (CO 3 )Cl] -, 4, Scheme 1. Since the carbonate concentration in blood and the cytosol is relatively high, ~24 mM, 4 is likely present under conditions of therapy. If enough Jurkat cells are present in the culture medium, 4 is not observable in the HSQC NMR spectrum, implying that it is rapidly taken up and/or modified by the cells (Tacka et al., 2004) .
In this report we use The molecular weight of modified 4 is < 3kDa and it is not detectable with HSQC NMR.
From the measured amounts of unmodified 4 remaining in the medium in the presence of This article has not been copyedited and formatted. The final version may differ from this version. In addition to the rate at which 4 disappears from solution, we measure the rate at which Pt becomes weakly attached to cells (removable by washing) and the rate at which Pt becomes strongly bound to and/or enters cells (not removable by washing). We also measure the rate at which Pt binds to nuclear DNA, since most evidence suggests that only Pt bound to nuclear DNA is effective in causing apoptosis. All three rates are proportional to extracellular cisplatin concentration, providing no evidence of saturation.
Comparing rates, we find that less than one per cent of the strongly bound (not removable) Pt is bound to nuclear DNA.
These results show that Jurkat cells use a previously undocumented defense mechanism to rapidly modify 4 to prevent it from entering the cytosol and reaching the nucleus. However, the defense signal is terminated when platinum, possibly as unmodified 4, enters the cell. Since the related platinum drug, carboplatin can also form a carbonato complex under biological conditions (Di Pasqua et al., 2006) , platinumcarbonato species may be responsible for the cytotoxicity of the platinum drugs.
This article has not been copyedited and formatted. The final version may differ from this version. (Tacka, et al., 2004) . The HSQC NMR spectra were collected in a capped tube at 37 o C using a Bruker DRX500 Advance Modification of the Mono-Carbonato Complex, 4, by Jurkat Cells. In order to determine the approximate molecular weight of the mono-carbonato complex which was modified by exposure to Jurkat cells, samples were passed through molecular weight cut-off filters and analyzed for platinum content using ICP-MS. Three samples each containing 5 million Jurkat cells suspended in 900 µL of culture medium and 20 µL of 3 mM stock cisplatin in 154mM NaCl (final total platinum concentration, 65 µM) were incubated under standard conditions in a humidified, 37 o C, 5% CO 2 atmosphere for 2 h after which time the cells were pelleted by centrifugation for 6-10 min at 200g. The supernatant from one sample was passed through a 50 kD filter (Amicon, Inc., Beverly, MA), while that from a second sample was passed through a 3 kD filter. In each case the filter was washed with 20 µL of deionized water with the wash being combined with the original filtrate to give a total volume of 940 µL. To the supernatant from the third sample, which was not passed through a filter, was added 20 µL of water. To all three samples were added 500 µL of a 70% (v/v) nitric acid/deionized H 2 O solution and the resulting mixture was heated at 70 o C for 24 h. Prior to analysis using ICP-MS (PerkinElmer/Sciex ELAN 6100), the samples were diluted to a final volume of 13 mL by the addition of deionized H 2 O. Within experimental error, all three samples yielded the same concentration of platinum indicating that all of the platinum in the culture medium has a molecular weight of < 3kDa. (Allison and Ridolpho, 1980) . Viabilities at the beginning of each experiment were ~94% and after a 6 h exposure to 65 µM cisplatin under the conditions described below they were ~74%. To each cell sample were added 20 µL of an aged (24 h) stock 3.0 mM solution of cisplatin (Sigma-Aldrich, St. Louis, MO), containing 154 mM sodium chloride, to give a final total platinum concentration of 65 µM.
Six of the samples were placed in capped Eppendorf tubes at 37 o C while the seventh sample (t = 0) was immediately pelleted in a centrifuge for 3 min at 200g.
Following centrifugation, the culture medium was removed from the cell pellet and 500 µL of the medium was reserved for analysis of its platinum content using ICP-MS. The cell pellet was resuspended in 1 mL of phosphate buffered saline (PBS) and the cells were pelleted by centrifugation. The supernatant was removed and 500 µL of the wash solution was reserved for analysis of platinum content using ICP-MS. The remaining cell pellet, containing platinum strongly bound to or taken up by the cells, was digested for 24 h at 70 o C in 500 µL of a 70% (v/v) nitric acid/deionized water to give a solution that was analyzed for its platinum content. The above procedure was carried out each hour using one of the remaining six samples (t = 1-6) and, in a separate set of experiments, the procedure was repeated with a total platinum concentration in the culture medium of 25 µM. Previous work has shown (Tacka et al., 2004 ) that exposure of Jurkat cells to 25 µM cisplatin for 3 h results in a significant loss in cell viabilities measured 24 h after exposure to drug.
Quantitation of Pt-DNA Adducts. Ten million Jurkat cells were incubated with various concentrations of cisplatin for 1, 1.5, or 3 h. The source of cisplatin was Platinol, which contains 3.3 mM cisplatin in 154 mM NaCl. After incubation under standard conditions in a humidified, 37 o C, 5% CO 2 atmosphere for the appropriate time and platinum concentration, cellular DNA was isolated and the number of Pt-DNA adducts determined as previously described (Sadowitz, et al., 2002) . Numbers of Pt-DNA adducts were calculated assuming 1 pg of Pt per µg of DNA corresponds to 1759 adducts per million nucleotides (using atomic weight of Pt = 195 g/mol and average molecular weight of a nucleotide = 343 g/mol). and 4 are observed (Centerwall, et al., 2005) in the culture medium, as shown in the spectrum of Figure 1 . The peak arising from cisplatin, 1, at 1 H/ 15 N, 4.09/-68.0, overlaps with one of the peaks of the mono-carbonato complex, 4a (N trans to Cl). The second peak for the mono-carbonato complex, 4b (N trans to CO 3 -2 ), appears at 1 H/ 15 N, 3.61/-80.5 in Figure 1 . Since peaks 4a and 4b should have equal intensities, the true intensity of peak 1 is the total intensity of the overlapped peak (1 + 4a) minus the intensity of 4b. All peak intensities decrease with time (Tacka et al., 2004) . The sum of peak intensities, extrapolated to t = 0, corresponds to the total concentration (65 µΜ) of all species at t = 0, making it possible to convert peak intensities at any time to concentrations.
Results

HSQC NMR Experiments.
Addition of Jurkat cells to the NMR solution causes a decrease in the intensity of the peak for 4b, Figure 1 , at the earliest time point. Since the decrease occurs within the time required to collect the first NMR data point, ~0.6 h, the cell-induced change in signal intensity is rapid. Cells cause little change in the peak intensity of 1 at this time (obtained by subtraction as above). The peak intensities for both 1 and 4b subsequently decrease with time, the former much more than the latter (Tacka et al., 2004) .
Measurements were made with 0.5, 1, 2, 3, 4, and 5 million Jurkat cells in 920 µL, usually for 20 h. Peak intensities for 4b were converted to concentrations of the monocarbonato complex, and [4] was fit to an exponential function of time, allowing estimation of the concentration of 4 remaining after the cells rapidly modified a portion of the compound, i.e., at t = 0.
The peak intensity for species 1 alone is calculated as half the difference between the intensity of the main peak (1 + 4a) and the intensity of the 4b peak. In Figure 2a The slope of the linear fit for 1 is zero within statistical error (2.9 ± 6.9) but the slope of the linear fit for 4b is definitely negative (-7.2 ± 2.3). The zero slope for cisplatin implies that the concentration of 1 at t = 0 is independent of the number of cells. Then, noting that, in the absence of cells, the total peak intensity at t = 0 corresponds to 65 µΜ, we can calculate the initial concentration of 1 as 42.5 µΜ.
Knowing pmol of 4 so it is undetectable in the NMR experiment. As will be evident from the results below, modified 4 remains in the culture medium but it is incapable of being taken up by the cells.
From the signal intensity for 4b as a function of time after the cells have rapidly modified a portion of the compound, one finds that the concentration of the monocarbonato species decreases slowly (−1.1 ± 0.4 µΜ h -1 ). The rate is independent of how This article has not been copyedited and formatted. The final version may differ from this version. Uptake of Platinum by Cells. In an attempt to determine the fate of 4 after its rapid modification by cells, we exposed 5 million Jurkat cells to cisplatin and measured the amounts of platinum strongly bound to and/or taken up by the cells (not removable by washing), loosely bound to the cells (recovered in the cell wash), and remaining in the culture medium. The results of two series of such measurements, for 65 µΜ and 25µΜ total platinum, are shown in Figure 3 . Squares correspond to platinum in the medium, X's to platinum taken up by the cells, and triangles to platinum in the washes.
Measured amounts of platinum have been converted to platinum concentrations in the original solution. Thus, since 65 µΜ total platinum was used in the first experiments, a concentration of 6.5 µΜ corresponds to 10% of the total amount of platinum added to the system. The concentrations were also renormalized so the sum of concentrations for each time is 65 µΜ (Figure 3a Similarly, we found that, when 65 µΜ cisplatin is used, 0.828 µΜ cisplatin is loosely attached to cells but removable by washing, independent of the incubation time;
when 25 µΜ cisplatin is used, 0.181 µΜ cisplatin is loosely attached but removable by washing. Since the ratio is 0.22, which agrees with the ratio calculated from the values of
[Pt] o , the loosely bound platinum is on the exterior surface of the cell. Since platinum must reach the cell surface before it can enter, this supports the idea that modified 4 is This article has not been copyedited and formatted. The final version may differ from this version. Platinum Binding to DNA. In connection with a study (Tacka, et al., 2004) .33 % of the platinum that enters the cell is bound to genomic DNA. Thus, most of the intracellular platinum is bound to proteins or small molecules, e.g. glutathione (Eastman, 1999) or it remains inside the cell in a form which is not readily removed by washing.
Discussion
From our studies it is not possible to tell if cisplatin, 1, or the monocarbonato complex, 4, or both are entering the cell. However, DNA binding most likely takes place through 4, or possibly its protonated bicarbonate analog. In order for 1 to bind to DNA, it would first have to aquate to form 2, which, as shown in Scheme 1, is in a rapid proton This article has not been copyedited and formatted. The final version may differ from this version. (Miller and House, 1990; Berners-Price and Appleton, 2000) . Since dissolved carbon dioxide in the cytosol could rapidly react with 3 to produce the monocarbonato complex 4 (Palmer and van Eldik, 1983; Acharya, et al., 2004; Centerwall, et al., 2005) , 1 on entering the cell would be rapidly transformed into 4, which would interact with cellular components including DNA. We recently showed that cisplatin reacts with pBR233 DNA in carbonate buffer to produce mono-functional DNA adducts which do not induce the same conformational changes in DNA as the well-known bifunctional 1, 2 intrastrand crosslink formed in the absence of carbonate (Binter, et al. 2006) . It is widely accepted that the nature of the platinum lesions on DNA is important for the induction of apoptosis (Eastman, 1999; Wang and Lippard, 2005) , so this observation is significant and suggests additional study.
Since more than 99% of the Pt which enters cells does not bind to DNA, it must react with other substances in the cytosol, or bind to extranuclear cell structures. Some authors (Lindauer and Holler, 1996) have distinguished between "chemically reactive platinum," defined as intracellular platinum able to react with calf thymus DNA, and "inactive platinum." The latter may be inactive because it has reacted with substances in the cytosol; it is possible that the reacted intracellular Pt is responsible for the termination of the cellular defense mechanism which modifies 4. As shown above, after the rapid Comparing uptake rates of Pt is complicated by the fact that there are many different ways of defining and measuring uptake. If uptake is defined as the difference between the concentrations of Pt in the medium in the presence and absence of cells, it is subject to the objection that the cells may modify the form of Pt, making it undetectable by the measurement technique used. A better definition is the amount of Pt actually found associated with cells, determined by analyzing the cells for platinum after removal of the culture medium. As has been pointed out (Ghezzi, et al., 2004) , this combines Pt which has actually entered the cells and Pt which is attached to the cell surfaces. One can partly distinguish between the two by washing the cells and analyzing the wash liquids for Pt, as we have done. The platinum which has actually entered the cells may be further divided into Pt bound to the nuclear DNA, Pt in an "active" form in the cytosol (Lindauer and Holler, 1996) , etc. In addition, Pt uptake has been reported as intracellular concentration of Pt, as Pt atoms per mass of cellular protein, or otherwise.
This article has not been copyedited and formatted. The final version may differ from this version. A review of earlier work on intracellular accumulation of cisplatin was given by Gately and Howell, 1993) . Mann et al. (1990) (Centerwall, et al., 2005) , uptake and DNA binding of cisplatin-carbonato compounds were probably measured in these studies. Assuming 6×10 9 nt cell -1 and ~300
This article has not been copyedited and formatted. The final version may differ from this version. This process appears to be a hitherto undocumented defense by the cell against a toxic form of cisplatin and it could be an additional mechanism of resistance to cisplatin.
However, unlike other resistance mechanisms which operate after the drug enters the cell, e.g., reaction with thiols or enhanced platinum adduct repair (Siddik, 2003; Kartalou and Essigmann, 2001, Brabec and Kasparkova, 2005) , this mechanism of detoxification appears to take place outside the cell and to be selective for one form of the drug, 4, in the culture medium. It is also possible that, instead of being modified outside the cell, 4 is absorbed by the cell, modified inside, and ejected into the medium on a rapid time scale.
Additional work will be needed to determine the mechanism by which 4 is modified, the nature of the products formed, and to what extent the process is related to a previously identified resistance mechanism broadly described (Kartalou and Essigmann, 2001 ) as "drug efflux" from the cell.
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